BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220929T140000
DTEND;TZID=Europe/Stockholm:20220929T150000
DTSTAMP:20260404T065356
CREATED:20220913T160723Z
LAST-MODIFIED:20220913T161924Z
UID:10000681-1664460000-1664463600@www.scilifelab.se
SUMMARY:Context crosstalk of macrophages in cardiovascular disease
DESCRIPTION:Erik A.L. Biessen\, Maastricht University\, the Netherlands \n\n\n\n\n\n\n\n\n\n\nIn this paper\, Biessen et al. introduce a novel approach that integrates 15-plex multispectral immunofluorescent microscopy with mass spectrometry imaging to reveal murine atherosclerotic plaque myeloid heterogeneity. It maps the phenotypes’ tissue localization while allowing their further histological characterization and correlations with their cellular and molecular microenvironmental contexts. \nProf. Erik Biessen graduated in Biophysical Chemistry at Groningen University\, Netherlands (1985). He joined the Division of Biopharmaceutics of Leiden University (Prof. Dr. Th.J.C. Van Berkel) as a post-doctoral fellow and was selected for the prestigious Netherlands Heart Foundation (NHF) funded Molecular Cardiology Program to become Established Investigator in 2001. Dr. Biessen received an innovational research incentive premium of N.W.O in 2001 (VIDI/VICI precursor)\, acquired a second Established Investigatorship of the NHF in 2004\, and was appointed Professor in Therapeutic Gene Modulation at Leiden University in 2005. Since 2007 he is heading the Experimental Vascular Pathology group of CARIM (MUMC). Dr. Biessen has a part-time affiliation at the Institute for Molecular cardiovascular research of RWTH Aachen\, Germany since 2015. Dr. Biessen is/has been a board member of NHS-CVON ( 2010- 2013)\, Dutch Atherosclerosis Society (>2008)\, ZonMW TOP grant committee\, FWO Med6 Expert panel of FWO\, and Ph.D. assessment board of IWT (both Belgium). He is a scientific adviser of VantageView (St Louis\, USA)\, associate editor of Cardiovascular Research and Atherosclerosis\, and participates in several European research programs (e.g. ERA-CVD-AtheroMacHete\, 3 H2020 ITNs (Intricare\, Evolution\, CareSYAN)\, Interreg-EMR Healthy Ageing and EurLipids). Dr. Biessen aims for curiosity-driven cross-disciplinary research with an open eye for the valorization of findings. Through the years his focus has shifted from biophysical chemistry\, via medicinal chemistry and drug targeting to pathomechanistic studies of cardiovascular diseases (>2001)\, with a main emphasis on inflammation.
URL:https://www.scilifelab.se/event/context-crosstalk-of-macrophages-in-cardiovascular-disease/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SysMedicine":MAILTO:cheng.zhang@scilifelab.se
END:VEVENT
END:VCALENDAR